Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicateStaphylococcus epidermidisbiofilms on silicone catheters

Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria

(2016) Giovanna Batoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Mechanisms of biofilm inhibition and degradation by antimicrobial peptides

(2015) L. Segev-Zarko et al.   BIOCHEMICAL JOURNAL

BaAMPs: the database of biofilm-active antimicrobial peptides

(2015) Mariagrazia Di Luca et al.   BIOFOULING

Naturally Occurring Peptides from Rana temporaria: Antimicrobial Properties and More

(2015) Maria Luisa Mangoni et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or L-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections

(2015) D. Lebeaux et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis

(2015) Anna M. Piras et al.   Frontiers in Microbiology

Temporins A and B Stimulate Migration of HaCaT Keratinocytes and Kill Intracellular Staphylococcus aureus

(2014) A. Di Grazia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains ofStaphylococcus epidermidis

(2014) Franca Lisa Brancatisano et al.   BIOFOULING

Novel approaches to combat bacterial biofilms

(2014) Christophe Beloin et al.   CURRENT OPINION IN PHARMACOLOGY

Potential Application of Antimicrobial Peptides in the Treatment of Bacterial Biofilm Infections

(2014) Nikola Strempel et al.   CURRENT PHARMACEUTICAL DESIGN

Quorum Sensing Inhibitors as Anti-Biofilm Agents

(2014) Gilles Brackman et al.   CURRENT PHARMACEUTICAL DESIGN

Antibiotic lock therapy: review of technique and logistical challenges

(2014) Brandon Bookstaver et al.   Infection and Drug Resistance

Mini-review:Staphylococcus epidermidisas the most frequent cause of nosocomial infections: old and new fighting strategies

(2013) F. Gomes et al.   BIOFOULING

Full and Broad-SpectrumIn VivoEradication of Catheter-Associated Biofilms Using Gentamicin-EDTA Antibiotic Lock Therapy

(2012) Ashwini Chauhan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivities of Antibiotics and Antimicrobial Cationic Peptides Alone and in Combination against Methicillin-Resistant Staphylococcus aureus Biofilms

(2012) Emel Mataraci et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis

(2012) Anastasia I Spiliopoulou et al.   BMC MICROBIOLOGY

Mini-review: Antimicrobial central venous catheters – recent advances and strategies

(2011) Cláudia Sousa et al.   BIOFOULING

The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation

(2011) Seong-Cheol Park et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci

(2011) Jeffrey B Kaplan et al.   JOURNAL OF ANTIBIOTICS

Sulfhydryl compounds reduce Staphylococcus aureus biofilm formation by inhibiting PIA biosynthesis

(2010) Xiaoqian Wu et al.   FEMS MICROBIOLOGY LETTERS

Current concepts in biofilm formation ofStaphylococcus epidermidis

(2010) Paul D Fey et al.   Future Microbiology

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America

(2009) Leonard A. Mermel et al.   CLINICAL INFECTIOUS DISEASES

In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1–18) in combination with conventional antibiotics against Stenotrophomonas maltophilia

(2009) Giuseppantonio Maisetta et al.   PEPTIDES